Bilcare Ltd. (BSE: 526853) is a Pune, Maharashtra-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹224 Cr, it ranks #2,566 by market cap among the 6,137 Indian listed companies on FinBizNet, and #5 of 10 in Life Sciences Tools and Services. At ₹83.85 (as of 25 Oct 2026), the share price is 25.8% below its 52-week high of ₹113.00 and 0.0% above its 52-week low of ₹83.85.
| Current Price | ₹83.85 |
|---|---|
| Market Cap | ₹224 Cr |
| BSE Code | 526853 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 122.4 |
| Return on Equity | -5.21% |
| Return on Assets | 1.76% |
| 52-Week Range | ₹83.85 – ₹113.00 |
| 3-Month Price Change | +46.5% |
| Beta (1Y) | 1.06 |
| Dividend Yield | 0.00% |
| Headquarters | Pune, Maharashtra |
| Website | www.bilcare-group.com |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit. Bilcare Limited was incorporated in 1987 and is headquartered in Pune, India.
1. Pharma Packaging Research Solutions-This segment provides pharma packaging research solutions.
1. Pharma Packaging Research Solutions & Its Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Indegene Ltd | ₹14,413 Cr | 35.2 | 13.94% | ₹1,063 Cr | +5.9% |
| Suven Life Sciences Ltd. | ₹8,583 Cr | -24 | -78.80% | ₹4 Cr | +30.6% |
| Vimta Labs Ltd | ₹2,338 Cr | 29.3 | 18.55% | ₹109 Cr | -32.5% |
| Tarsons Products Limited | ₹1,762 Cr | 117.2 | 2.26% | ₹110 Cr | +3.3% |
| Bilcare Ltd. | ₹224 Cr | 122.4 | -5.21% | — | — |
| Brooks Laboratories Ltd. | ₹199 Cr | 8.1 | 22.28% | ₹23 Cr | -53.0% |
| Jeevan Scientific Technology Ltd | ₹178 Cr | 130.4 | 1.68% | — | +34.0% |
| Vivo Bio Tech Ltd. | ₹31 Cr | -16.6 | -2.00% | ₹14 Cr | -55.7% |
| Dr. Habeebbullal Life Sciences Ltd | ₹28 Cr | -2.8 | -68.79% | — | -32.7% |
Listed by market capitalisation. Ratios are shown for context only.
Bilcare Ltd. is trading at ₹83.85, with a market capitalisation of ₹224 Cr.
Bilcare Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Bilcare Ltd. has a P/E of 122.4 and a return on equity of -5.21%.
Bilcare Ltd. is listed on the BSE under the scrip code 526853.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.